Oncology Institute (TOI) Competitors $3.79 +0.10 (+2.71%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$3.80 +0.00 (+0.13%) As of 08/22/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TOI vs. TDOC, AHCO, OMDA, GRAL, PNTG, FTRE, FLGT, CDNA, CSTL, and AUNAShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Teladoc Health (TDOC), AdaptHealth (AHCO), Omada Health (OMDA), GRAIL (GRAL), The Pennant Group (PNTG), Fortrea (FTRE), Fulgent Genetics (FLGT), CareDx (CDNA), Castle Biosciences (CSTL), and Auna (AUNA). These companies are all part of the "healthcare" industry. Oncology Institute vs. Its Competitors Teladoc Health AdaptHealth Omada Health GRAIL The Pennant Group Fortrea Fulgent Genetics CareDx Castle Biosciences Auna Teladoc Health (NYSE:TDOC) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Is TDOC or TOI more profitable? Teladoc Health has a net margin of -8.16% compared to Oncology Institute's net margin of -14.26%. Teladoc Health's return on equity of -10.13% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Teladoc Health-8.16% -10.13% -4.43% Oncology Institute -14.26%-1,527.21%-34.25% Do analysts recommend TDOC or TOI? Teladoc Health presently has a consensus target price of $9.75, indicating a potential upside of 27.05%. Oncology Institute has a consensus target price of $7.00, indicating a potential upside of 84.70%. Given Oncology Institute's stronger consensus rating and higher possible upside, analysts clearly believe Oncology Institute is more favorable than Teladoc Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teladoc Health 0 Sell rating(s) 12 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.33Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Do institutionals & insiders believe in TDOC or TOI? 76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 36.9% of Oncology Institute shares are held by institutional investors. 0.6% of Teladoc Health shares are held by company insiders. Comparatively, 8.5% of Oncology Institute shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, TDOC or TOI? Teladoc Health has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Does the media favor TDOC or TOI? In the previous week, Teladoc Health had 3 more articles in the media than Oncology Institute. MarketBeat recorded 6 mentions for Teladoc Health and 3 mentions for Oncology Institute. Teladoc Health's average media sentiment score of 1.13 beat Oncology Institute's score of 0.88 indicating that Teladoc Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Oncology Institute 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings and valuation, TDOC or TOI? Oncology Institute has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeladoc Health$2.54B0.53-$1.00B-$1.19-6.45Oncology Institute$393.41M0.86-$64.66M-$0.68-5.57 SummaryTeladoc Health beats Oncology Institute on 9 of the 17 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TOI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$329.27M$7.70B$5.76B$9.58BDividend YieldN/A2.71%4.41%4.10%P/E Ratio-5.5778.4731.1026.04Price / Sales0.8649.18433.45102.77Price / CashN/A24.6737.7358.48Price / Book-37.9024.799.536.61Net Income-$64.66M$243.33M$3.26B$265.56M7 Day Performance0.80%1.08%2.10%1.97%1 Month Performance2.16%-0.65%2.81%-0.36%1 Year Performance924.60%10.34%30.56%19.03% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute2.8805 of 5 stars$3.79+2.7%$7.00+84.7%+996.0%$329.27M$393.41M-5.57660Short Interest ↓TDOCTeladoc Health3.0632 of 5 stars$7.48-0.5%$9.76+30.5%+8.0%$1.33B$2.57B-6.295,500Positive NewsAHCOAdaptHealth4.3501 of 5 stars$9.38-1.1%$13.40+42.9%-4.8%$1.28B$3.26B17.3710,500Positive NewsOMDAOmada HealthN/A$20.91+1.9%$24.57+17.5%N/A$1.18BN/A0.00849News CoveragePositive NewsGRALGRAIL1.0223 of 5 stars$32.80+1.1%$31.50-4.0%+107.0%$1.17B$125.60M-2.501,360Insider TradePNTGThe Pennant Group3.8371 of 5 stars$25.11-0.6%$33.40+33.0%-24.2%$873.04M$695.24M32.197,000FTREFortrea3.8576 of 5 stars$7.92-1.5%$13.30+67.9%-61.0%$730.03M$2.73B-0.7015,500FLGTFulgent Genetics3.6985 of 5 stars$21.52+1.2%$25.33+17.7%-5.6%$650.75M$283.47M-12.961,313Positive NewsCDNACareDx4.3227 of 5 stars$11.85+0.1%$27.67+133.5%-58.1%$630.21M$340.83M11.62740Positive NewsCSTLCastle Biosciences2.7215 of 5 stars$20.56+2.3%$37.00+80.0%-24.3%$582.78M$332.07M-58.74540Positive NewsAUNAAuna4.3623 of 5 stars$6.27-0.7%$10.70+70.8%-17.7%$467.02M$1.17B10.8014,842News CoverageEarnings ReportAnalyst Upgrade Related Companies and Tools Related Companies Teladoc Health Alternatives AdaptHealth Alternatives Omada Health Alternatives GRAIL Alternatives The Pennant Group Alternatives Fortrea Alternatives Fulgent Genetics Alternatives CareDx Alternatives Castle Biosciences Alternatives Auna Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOI) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access